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Abstract
Cell division and differentiation are two fundamental physiological processes that need to be tightly balanced to achieve
harmonious development of an organ or a tissue without jeopardizing its homeostasis. The role played by the centriolar
protein STIL is highly illustrative of this balance at different stages of life as deregulation of the human STIL gene expression
has been associated with either insufficient brain development (primary microcephaly) or cancer, two conditions resulting
from perturbations in cell cycle and chromosomal segregation. This review describes the recent advances on STIL functions
in the control of centriole duplication and mitotic spindle integrity, and discusses how pathological perturbations of its
finely tuned expression result in chromosomal instability in both embryonic and postnatal situations, highlighting the
concept that common key factors are involved in developmental steps and tissue homeostasis.
Facts
● STIL is a cell cycle-regulated protein specifically
recruited at the mitotic centrosome to promote the
duplication of centrioles in dividing cells.
● Complete loss of STIL results in no centrosomes, no
cilia, and is not compatible with life.
● By contrast, residual or increased expression of STIL
is viable but alters the centriole duplication process
leading to either impaired or excessive centrosome
formation.
● Genetic mutations in human STIL result in either
residual expression or stabilization of STIL at the
centrosome both leading to mitotic spindle defects
and primary microcephaly (MCPH7).
● Abnormally high expression of STIL in differentiated
tissues triggers centrosomal amplification and is
associated with an increased metastatic potential in
multiple cancers.
Open questions
● Centrosome amplification is seen both in cancer and
in MCPH phenotype. How is the context important
in determining the phenotype?
● Is presence of STIL in the centrosome important in
determining cell fate?
● STIL has several binding partners. To what extent is
the STIL phenotype due to the independent functions
of these binding partners?
Introduction
The developing brain appears particularly sensitive to
centrosome dysfunction, which is also associated with a
wide range of cancers. The centrosome is a cytoplasmic
organelle built around microtubule-based core compo-
nents called centrioles. This review focuses on the STIL
gene that encodes a regulatory protein necessary for
centriole biogenesis and is expressed in many cell types.
The structure and function of STIL is described followed
by an account of two phenotypes that have been asso-
ciated with STIL dysfunction, autosomal recessive pri-
mary microcephaly (MCPH), and cancer. Reasons for
these different phenotypes are discussed in relation with
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centriole duplication and mitotic checkpoints that operate
in different cellular contexts to deal with aneuploidy and
chromosomal instability.
STIL structure
The human STIL gene was initially identified in a
common chromosomal rearrangement in T-cell acute
lymphoblastic leukemia and named SCL/TAL1 Inter-
rupting Locus (SIL/STIL)1. It is predicted to encode five
isoforms. Isoform1 (NP_001041631.1; henceforth referred
to as STIL) is a 1288-amino-acid protein; isoform2 has
1287 amino acids (NP_001269865.1) and differs from
isoform1 by a missing serine875; isoforms3–5
(NP_001269866.1, NP_001269867.1, NP_001269868.1)
have several amino acids missing but their significance is
unknown. STIL contains conserved regions and interacts
with several proteins (Fig. 1). CR2 (amino acids 385–499)
is a proline-rich domain that includes the conserved
PRXXPXP motif, which interacts with the Centrosomal
P4.1-Associated Protein (CPAP/CENPJ). The coiled-coil
domain (amino acids 721–748) is important both for
Polo-Like Kinase 4 (PLK4) and Cyclin Dependent Kinase
1 (CDK1 also known as CDC2)/CyclinB binding2,3 and for
STIL oligomerization4. The STAN domain (amino acids
1052–1148) mediates the binding of the centriole protein
SAS-62. At the C terminus is the KEN box involved in
Anaphase-Promoting-Complex/Cyclosome (APC/C)-
mediated degradation of STIL5. The C terminus of STIL
can also interact with conserved components of the
Hedgehog signaling such as Suppressor-of-fused homolog
(SUFU)6 and GLI17.
STIL function in centriole duplication
The centriole is an evolutionarily conserved structure
consisting of a ninefold symmetric cartwheel with micro-
tubule triplets, and thought to have been present in the Last
Eukaryotic Common Ancestor8. The centrosome has two
centrioles orthogonal to each other, surrounded by proteins
constituting the pericentriolar material (PCM). Both the
centriolar core and the PCM nucleate microtubules, which
are important for positioning the mitotic spindles and
imparting polarity and asymmetry to the cell. During cell
division the centrioles duplicate only once; STIL and its
interactors are central to this process, ensuring the fidelity
of this unique duplication, thereby minimizing chromo-
some instability9. STIL transiently associates with PLK4
and SAS-6 to form the core module for centriole dupli-
cation10. PLK4 is related to the Polo-kinase family of
serine/threonine kinases and initiates centriole forma-
tion11,12, while SAS-6, a coiled-coil protein that self-
assembles into the ninefold symmetry gives the carthweel
its shape13,14. STIL and PLK4 are initially maintained at
low levels in non-dividing and differentiated cells15: STIL
forms dimers or tetramers through its CC domain and is
degraded in the cytoplasm by APC/C and its co-activator
CDC20, through recognition of the KEN motif4,5. STIL
Fig. 1 Conserved regions, functional domains, and genetic mutations in the human STIL protein. Blue and orange boxes represent regions of
the protein that are highly conserved across species (CR conserved region, CC Coiled-Coil domain, STAN STIL/Ana2 domain, KEN Box Conserved Lys-
Glu-Asn residues). Double-headed arrows indicate known interactions with STIL. Known phosphorylated residues in 871, 873, 874, 1116, and 1250 are
indicated by a red line. Human mutations predicted to truncate the protein are displayed in red and missense mutations are in green
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level in the cytoplasm rises in G1 because its degradation
by APC/C is prevented by the absence of CDC205. PLK4
recruits STIL at the base of the parental centriole through
the CC domain and phosphorylates the STAN domain at
the late G1/G1-S transition16–18. Phosphorylated STIL
then promotes its binding to the C-terminal region
of SAS-6 and recruits it to the outside wall of the cen-
triole2,17. This core module along with CPAP, also
recruited by STIL to the centriole, starts the assembly of
the cartwheel and centriole duplication19,20. At early S
phase, the centrosome-associated protein ROTATIN was
recently shown to associate with STIL and contribute to
building full-length centrioles21. At S–G2 transition, the
centrioles are duplicated but remain close to each other,
potentially preventing reduplication. Remarkably, CDK1,
transiently expressed at late G2 and during M phase,
competes with PLK4 for binding to the CC domain of
STIL, preventing PLK4 from recruiting STIL until mitosis
is completed3,16,22. The spindle assembly checkpoint, a
highly conserved mechanism also called mitotic check-
point, prevents the degradation of CDK1 during mitosis
by the inhibition of APC/C-CDC20 until all chromosomes
are properly segregated23. CDK1 is thought to trigger
progressive dissociation of STIL and SAS-6 from early
mitotic centrosomes, thereby initiating cartwheel dis-
assembly during M phase and ensuring that centriole
biogenesis occurs only once before cell divides5. Upon
activation, APC/C-CDC20 degrades CDK1 for entry into
anaphase and again marks STIL for degradation until next
the G1 phase. Thus, by prometaphase there is no STIL at
the centrosome and by anaphase there is no STIL in the
cytoplasm either until upon mitotic exit APC/C is blocked
and STIL levels builds up once again in G1 (Fig. 2).
STIL function in SHH signal transduction
SHH is a morphogen involved in patterning, prolifera-
tion, and survial of neural stem cells during development24.
SHH binds to its receptor Patched thereby relieving its
inhibition on Smoothened and resulting in the activation of
GLI transcription factors. That GLI proteins are the main
downstream effectors for SHH signaling is borne out by the
fact that activated GLI can rescue the loss-of-function of
SHH and lead to proliferation and increased cell survival25.
The initial findings that STIL participates in the control of
SHH signaling came from Stil−/− mouse embryos, which
showed a marked reduction of Patched and Gli1 expres-
sion26. Interestingly, Stil−/− mutants also lack primary
cilia27, a structure present in almost all cell types, which is
assembled beneath the plasma membrane, by the protru-
sion of the microtubule-based axoneme. During interphase,
the mother centriole and its appendages constitute the
basal body, from which the axoneme elongates28,29. STIL
requirement for cilia formation likely stems from its
function in supporting centriole biogenesis and stability.
Receptors for SHH are abundant on cilia membranes
allowing cilia to act as receivers of signals and as platforms
where downstream effectors can be modified30. Thus, cilia,
whose presence depends on STIL, are required for activity
of the SHH pathway31.
STIL also interferes with the SHH pathway in a direct
manner, by interacting with SUFU. SUFU acts as a
negative regulator of SHH by tethering GLI1 in the
cytoplasm. STIL binds to SUFU in the cytoplasm of
pancreatic cancer cells, thus releasing GLI1 for tran-
scription of SHH-downstream genes6. In PC12 cells, STIL
interacts with the SUFU/GLI1 complex, and its down-
regulation results in a decrease in both SHH signaling and
cell proliferation7. A similar correlation has been evi-
denced in zebrafish retina cells, further suggesting that
STIL plays a role in cell proliferation through the SHH
pathway32 (Fig. 3).
Consequences of STIL deregulation
Given the centrality of STIL in centrosome duplica-
tion and cilium biogenesis, deregulation of STIL is
predictably profound. Stil−/− embryos die at midgesta-
tion with axial midline defects, resulting from aberrant
SHH signaling26. MEFs derived from Stil−/− embryos
show a marked decrease in mitotic index, and Stil
knockdown results in the absence of identifiable cen-
trosomes during interphase and multiple spindle poles
with disrupted γ-tubulin signals during mitosis33, as
well as in the loss of primary cilia27. Conversely, STIL
overexpression causes centrosome amplification,
resulting in a star-like pattern around the parental
centriole, consistent with a role of STIL in the onset of
procentriole formation. Accordingly, this star-like
structure is positive for the centriolar proteins CP110
and centrin20,34. Mutations within the various domains
of STIL give predictable phenotypes. When the CR2
domain or the CC domain or the STAN domain is
deleted, there is no centrosomal duplication16,18,
whereas removal of the KEN box leads to centrosome
amplification due to the inability of STIL to be degra-
ded5. However, both overduplication and lack of
duplication of centrosomes lead to abnormal mitotic
spindle assembly and consequently increase the chances
of abnormal chromosomal segregation and aneuploidy.
Another consequence of STIL deregulation is the
indirect effect on interacting partners. STIL binding to
PLK4 supresses PLK4 auto-inhibition, thereby allowing its
trans-phosphorylation and protecting activated PLK4
from degradation35. Conversely, depletion of STIL leads
to a marked accumulation of PLK4 in an inactive con-
formation. Therefore, changes in STIL levels have
immediate consequences on PLK4 activation levels10,17.
STIL also negatively regulates Chfr, an E3 ligase that
blocks mitotic entry in response to mitotic stress.
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No direct interaction between STIL and Chfr has been
shown, but STIL expression results in an increase of Chfr
auto-ubiquitination, thereby promoting its proteasomal
degradation and proper progression of cells through
mitosis33. Data support a role of Chfr in defective mitotic
progression associated with reduced activation of
CDK1/CYCLIN B and centrosomal abnormalities caused
by the lack of STIL33. Thus, STIL deregulation likely
impacts the activation level of CDK1/CYCLIN B and
the timing of entry into mitosis, through its regulation
of Chfr.
STIL expression during human brain development
STIL is expressed in both fetal and adult tissues. How-
ever, its expression levels fluctuate with the cell cycle,
making it difficult to detect in whole tissue, especially if
the cells are not synchronized. Indeed, it is detected more
easily in cancer cell lines and tissue where it is over-
expressed36,37. The BrainSpan Atlas (http://www.
brainspan.org/) and the BrainCloud database (http://
braincloud.jhmi.edu) show its expression pattern during
brain development. The association of STIL with cell
proliferation is borne out by its expression pattern during
fetal stages. At 15 postconceptional weeks STIL is strongly
expressed in the ventricular and subventricular zones of
the forebrain, the ganglionic eminence and the rostral
migratory stream, and less expressed in intermediate
zone, subplate, cortical plate, marginal zone, and sub-
granular layer of the forebrain. This pattern persists at 21
postconceptional weeks, although the expression is
Fig. 2 STIL regulation during the cell cycle. Six phases of the cell cycle are represented. a Early G1 phase: STIL levels are low in the cytoplasm
and STIL is absent at the centrosome. b, c G1–S and S phases: STIL levels are high in the cytoplasm and STIL starts being associated with the
centrosome. PLK4 interacts and phosphorylates STIL. STIL recruits SAS-6 and CPAP to the centrosome, contributing to the assembly of the cartwheel.
The procentriole starts elongating in S phase. d G2 phase: the two centrosomes begin to move apart. CDK1/CYCLIN B is active. Centrosome
orientation checkpoint. e The nuclear envelope breakdown occurs, CDK1 binds to STIL and moves it to the cytoplasm, there is no more STIL at the
centrosome, cartwheel disassembles. Spindle assembly checkpoint. f Anaphase, APC/C is fully active, cytoplasmic STIL is degraded. The cell nucleus or
chromosomes with their mitotic spindle are represented in blue. Centrioles are shown in dark blue. STIL is represented by a yellow donut surrounded
by a red circle when phosphorylated. PLK4 is represented by a red dot, CDK1/CYCLIN B by a black dot, SAS-6 by a small green hexagon, CPAP/CENPJ
by a small pink hexagon, and APC/C by a black and white C-shape. Centrosome orientation and spindle assembly checkpoints are indicated by
green/red tick boxes
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reduced in the subventricular zone. The expression of
PLK4, SAS-6, and CPAP also broadly shows this pattern of
expression, although the expression of SAS-6 and STIL
diverges in some regions of the cortical plate. In the
cerebellum, STIL, PLK4, and SAS-6 but not CPAP are
expressed in the external granule layer and regions of the
rhombic lip. However, none of these genes are expressed
in the transient Purkinje cell cluster, the ventricular
matrix zone of the cerebellum or in the migratory streams
of the hindbrain. Microdissection experiments at different
developmental stages confirmed that STIL expression is
high in the ventricular zone and low in the subplate and
cortical zones (http://www.brainspan.org/). Further,
microdissected diencephalon did not have STIL (http://
www.blueprintnhpatlas.org/). This suggests that (i) the
structural components of the cartwheel STIL-SAS-6-
PLK4 is by no means obligatory for centrosome duplica-
tion in all cells and (ii) STIL is present in specific popu-
lations of dividing cells.
STIL mutations and primary microcephaly
Microcephaly (small brain size) is indirectly diagnosed
by a head circumference smaller than the age-specific and
gender-adjusted mean by more than 2 standard deviations
(S.D.s) at birth. Primary microcephaly refers to hereditary
microcephalies already detectable in utero. Most of them
are autosomal recessive and include (i) isolated forms
called MicroCephaly Primary Hereditary (MCPH), (ii)
forms associated with growth retardation, called micro-
cephalic dwarfism. Most of STIL mutations identified in
patients are associated with a MCPH phenotype and STIL
is recognized as MCPH738–40. However, a few patients
exhibit criteria of microcephalic dwarfism, as short stature
has been reported41. So far, eight mutations in STIL have
been described in 37 patients all showing severe micro-
cephaly (−4 to −10 S.D.). Five mutations are splice42,43,
deletion, nonsense43, or duplication44 that predict the
production of truncated proteins, while three mutations are
missense substitutions44–46 (Fig. 1). Despite the different
Fig. 3 STIL and SHH signaling at the cilium. A cilium and its axonemal structure are represented in three different contexts of expression of SHH
and STIL. SMO = SMOOTHENED receptor, PTC = PATCHED receptor. a In resting or differentiated cells, there is no SHH and low STIL expressed in the
cilium. The PTC receptor is expressed at the membrane while the SMO receptor is degraded in the cytoplasm. SUFU binds and tether GLI proteins in
the cytoplasm, blocking GLI-dependent transcription. b When SHH is expressed, it binds to its receptor PTC inducing its internalization and
degradation in the cytoplasm. This allows SMO expression at the membrane of the cilium and leads to GLI derepression. c When STIL is abnormally
highly expressed during interphase, it becomes abundant in the cilium where it binds to SUFU, releasing GLI proteins and thus activating GLI-
mediated transcription even in the absence of SHH
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kinds of mutations, the various domains affected (Table 1),
and the report of lobar holoprosencephaly and partial
agenesis of the corpus callosum in addition to micro-
cephaly in some cases42,44,45, no clear genotype–phenotype
correlation has come out so far. However, the fact that
these mutations trigger a phenotype compatible with life
(although very severe) is surprising since genetic ablation of
STIL is embryonically lethal early during embryogenesis in
mice and fish26,47. This suggests that STIL mutations in
human do not result in a complete loss-of-function, or are
partially compensated by other genes. The first hypothesis
is supported by the findings that two C-terminal nonsense
mutations (p.Val1219* and p.Gln1239*), which result in the
loss of the KEN box43, do not affect the centrosomal
localization of STIL nor its functionality but rather abolish
its degradation by APC/C in late mitosis5. Removal of the
KEN box thus causes a strong accumulation of the mutant
protein, resulting in centrosome amplification5. Alter-
natively, microcephaly in MCPH7 patients can result from
a decrease of STIL levels. This was illustrated by rescue
experiments in U2OS cells showing that the pGly717Glu
mutation induces a reduced but non-null activity of STIL
on centriole duplication45. Another mutation, inducing
exon 5 skipping and frameshift in the STIL sequence, is
likely close to a null mutation as all domains are predicted
to be lost42. However exon skipping was only partial in the
patient analyzed, suggesting some residual activity of STIL,
and providing an explanation for the fact that this mutation
is compatible with life and the idea that MCPH7 micro-
cephaly can result from a decreased STIL activity. There-
fore, both accumulation and impairment of STIL protein
levels during cell cycle affect centriole regulation and result
in microcephaly (Fig. 4).
STIL deregulation and cancer
Centrosomes are essential for chromosomal stability,
and abnormalities of their number, or structure affect cell
division22. Considering the central role of STIL in main-
taining centrosome integrity in highly proliferating cells,
STIL has been found upregulated in several cancers of bad
prognosis, including lung cancer, colon carcinoma, pros-
tate adenocarcinoma36, and ovarian cancers48. Moreover,
STIL expression is associated with an increased metastatic
potential in multiple cancers49. As expected, STIL upre-
gulation is associated with a high histopathological
mitotic index in tumors36 and presumably affects the
formation of mitotic spindles, as well as SHH signaling
and the function of its interactors.
Fig. 4 Consequences of deregulating STIL expression levels. STIL expression levels are finely regulated both during development and in
differentiated tissues. While total absence of STIL is lethal during development, high STIL levels due to random somatic mutations in differentiated
tissues result in aneuploidy and/or high GLI-mediated transcription that can lead to cancer. Congenital deregulation of STIL (both a too high and a
too weak expression) leads to microcephaly by either reduced or amplified centrosome duplication, highlighting the importance of a tightly
regulated STIL expression
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Although cells can proliferate and microtubule can
nucleate in their absence, centrosomes are obligatory for
controlling spindle orientation50. Loss of this control
leads to spindle defects, especially in highly polarized
cells, where misoriented spindles influence daughter cell
positioning, possibly causing a disruption in tissue mor-
phology51. Several tumor suppressor genes such as APC,
or VHL, are important for stabilizing microtubules and
maintaining spindle orientation51. Similarly, over-
expression of genes such as STIL could act as oncogenes
and lead to cancer by promoting spindle defects, although
direct evidence of a link between oncogene activation and
spindle misorientation is lacking. STIL overexpression,
which results in supernumerary centrosomes, could lead
to cancer in inducing chromosomal instability10,52.
The role of STIL in promoting SHH signaling could be
another pathway to account for its association with can-
cer. Following the initial observation that SHH over-
expression results in the development of basal cell
carcinomas in mice53, a large body of literature has
implicated the SHH pathway in development of various
cancers including a subset of medulloblastomas54,55. STIL
overexpression in pancreatic adenocarcinoma was shown
to de-repress GLI1 from SUFU-mediated control and this
phenotype was reversed when STIL was downregulated6.
Thus, during the process of carcinogenesis, the increased
expression of STIL promotes the transcriptional activity of
GLI1, which is no longer regulated quantitatively. GLI1
upregulates genes that promote sustained proliferation,
cell death resistance, stemness, angiogenesis, and genomic
instability, which are hallmarks of cancer56. Therefore,
increase in STIL expression leading to uncontrolled GLI1
de-repression likely represents a crucial step toward
cancer progression.
MCPH and cancer—two conditions associated with
abnormal centrosome duplication
STIL loss-of-function results in embryonic lethality in
mice, fish, and most likely in human as well. MCPH7
phenotype reflects that perturbing the tuning of STIL
expression levels is compatible with life but triggers severe
patterning phenotypes during development, including
brain growth. Thus, microcephaly caused by STIL muta-
tions can result from either too less centrosome dupli-
cation or too much centrosome amplification (Fig. 4). In
both cases, the integrity of the mitotic spindle is com-
promised and cell divisions have a greater chance of
chromosomal instability. Similarly, the association of STIL
upregulation with various cancers reflects a deregulation
of STIL expression levels in specific tissues contributing
to genomic instability. What results in MCPH rather than
cancer could be the difference in mitotic checkpoints in
different contexts13,57. Centrosome orientation check-
point ensures that the centrosomes are duplicated and
appropriately positioned before entry into mitosis and
several centrosomal proteins such as CNN and SAS-6 are
part of this checkpoint58. This checkpoint may not be
present in all cells at all developmental stages but rather
in those cases where the cell division plane has important
outcomes59. In germline stem cells, for example, the
division plane determines the distribution of cell fate
determinants in daughter cells, helding cells at the G2–M
phase until their mitotic spindles are properly oriented58.
STIL downregulation results in disorganized mitotic
spindles resulting in a loss of spindle orientation con-
trol47. In cortical development, STIL mutations leading to
spindle orientation defects likely result in a depletion of
cortical progenitors due to cell death or premature dif-
ferentiation and give rise to a MCPH phenotype57 (Fig. 4).
PLK4 overexpression also results in centrosome amplifi-
cation and aneuploidy leading to a reduction in brain size
due to cell death60. Apoptosis inhibition in this back-
ground causes the accumulation of aneuploid cells unable
to proliferate efficiently, leading to premature neuronal
differentiation60, whereas in a P53−/− context, PLK4
overexpression results in aneuploidy and skin cancer61.
The spindle assembly checkpoint is the next checkpoint
once cells have entered mitosis and formed spindles. In
the absence of bipolar spindles, cells are held-up in pro-
metaphase and do not proceed to anaphase58, which
results in increased apoptosis62. However, cells can
increase their time in mitosis, thus adapting to this
checkpoint and can assemble bipolar spindles in the
absence of centrosomes or in the presence of super-
numerary centrosomes. First in the absence of centro-
some duplication cells manage to have bipolar spindles
even though there is no centriole attached to one of the
poles34. Second is a phenomena of centrosome clustering,
wherein multiple centrosomes are clustered to enable the
formation of bipolar spindles, a phenomenon whose effi-
ciency could be tissue-specific60. These divisions often
result in aneuploidy. When centrosome integrity is com-
promised, cells usually arrest in G1 and do not re-enter
cell cycle after a prolonged cytokinesis to avoid chromo-
somal instability22 and in many cases proliferation in the
absence of centrioles additionally requires the suppression
of P5317. Upregulation of STIL giving rise to aneuploidy
could play a major role in providing an evolving genome
to help the cells adapt to the changing environment of the
cancer and escape normal checkpoints. In the developing
cortex, abnormal mitotic spindles due to STIL mutations
would result in cell fate switches rather than cell hyper-
proliferation. However, that patients whose STIL muta-
tion is clearly associated with centrosome amplification
could be at risk of developing cancer cannot be ruled out.
Seventeen MCPH loci have been described so far40,
several of which also play a role in cancer. MCPH1 is an
early DNA damage response (DDR) protein and MCPH1
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deletions have been identified as a risk for breast cancer63.
Centrosome amplification is commonly seen following
DNA damage and can arise as part of the DDR64. The
serine-threonine kinase CHK1 plays a major role in DDR
by halting cell division in G2/M until repair proteins are
recruited at lesion sites. In this context, MCPH1 defi-
ciency potentiates CHK1 activity and increases centro-
some amplification65. Thus, compromising mitotic
checkpoints results in cell division in the presence of
abnormal centrosomes63,65. How CHK1 overactivation
leads to centrosome amplification is not fully understood,
but it is thought to activate CDK2, a cyclin-dependent
kinase required for centrosome duplication, likely through
activating its phosphorylation66,67. WD repeat-containing
protein62 (WDR62), whose deficiency is associated with
MCPH268–70, is required for maintaining spindle and
centrosome integrity. Its overexpression, coincident with
centrosome amplification, is also seen in lung adeno-
carcinomas and ovarian cancers71,72. WDR62 interacts
physically during the cell cycle with the abnormal spindle-
like microcephaly-associated protein (ASPM), whose
deficiency causes the most frequent primary microcephaly
(MCPH5)73. Here too, increased ASPM levels cause
tumor growth and are seen in medulloblastomas while its
reduction causes a decrease in tumor proliferation74.
CDK5RAP2 (MCPH3) is also involved in the DDR; it
functions by arresting cells before mitotic entry due to
imparied centrosomes but also interacts with BUB1 and
MAD2, which are important in spindle activation check-
point75,76. Interestingly, a correlation between cen-
trosomal abnormalities, aneuploidy, and cytogenic risk
profile is seen in acute myeloid leukemia, where gene
expression profiling has revealed the differential expres-
sion of genes encoding centrosomal and mitotic spindle
proteins77. Among these are pericentrin, a scaffold protein
that anchors many other proteins at the centrosome78 and
NuMA, which associates with dynein and microtubules to
create localized pulling forces, thus regulating the correct
assembly and positioning of the mitotic spindle79. The
role of such factors points to mitotic centrosomal
abnormalities as important component of cancer
progression.
STIL could also have an indirect effect on cancer, as a
downstream effector of PLK4. Increased PLK4 expres-
sion has been reported in malignancies such as colorectal
cancer80, pediatric medulloblastoma81, and breast
tumors82. Its transient overexpression leads to centro-
some overduplication and in a P53−/− background that
inhibits apoptosis, it results in aneuploidy and sponta-
neous skin cancer61. Another recent study has convin-
cingly shown that PLK4 overexpression leads to
spontaneous tumors in several organs83. It remains to be
seen whether this phenotype is dependent on STIL
expression. STIL binds to PLK4 in the cytoplasm and
therefore STIL expression levels could impact PLK4
cytoplasmic activity17, which functions to remodel the
cytoskeleton and may be important for cancer invasion
and metastasis as its depletion is correlated with an
increase in E-cadherin expression and less metastasis84.
CYCLIN B is also frequently found elevated in primary
breast cancer, esophageal squamous cell carcinoma,
laryngeal squamous cell carcinoma, and colorectal car-
cinoma85–89 and its expression indicates a bad prognosis
and is correlated with the malignancy of gynecological
cancers90. Downregulation of STIL decreases CDK1/
CYCLIN B activity, prevents G2–M transition, and cau-
ses inhibition of tumor growth in vivo91. Conversely,
increasing STIL could promote CDK1/CYCLIN B
activity and indirectly participate in CYCLIN B-
dependent proliferation in tumor cells. Absence of
STIL also results in an upregulation of Chfr, and lowers
PLK1, resulting in the activation of the CDC25c phos-
phatase. This pathway could thus control the entry of
cells into mitosis independent of its obligatory role in
centriole duplication33.
Conclusion
STIL mutations in MCPH show that centrosomes and
cilia are essential for normal brain development. During
evolution, one way that the cortex has undergone
expansion is likely linked to mechanisms controlling
spindle orientation and keeping the balance between
asymmetric and symmetric cell divisions92,93. A change in
the nature of spindle orientation control has been pro-
posed to account for the population of subventricular
zone progenitors in human development and based on the
strong expression of STIL in the ventricular zone, one
may speculate that STIL is important for controlling
spindle orientation in giving rise to subventricular zone’s
cells94. Deficiency of several centrosomal proteins results
in MCPH, and centrosomal proteins may thus be a key to
discovering the mechanism of expansion of cortical
area38. In addition, the involvement of STIL in cancer
shows that the result of spindle defects can be vastly
different depending on the stage of development and the
tissue involved that probably is partly due to differential
responses to mitotic checkpoint mechanisms. STIL
intersects several pathways, and lowering its level could
block the effects of PLK4 overexpression, CDK1/CYCLIN
B activation, and GLI1 signaling, and reduce proliferation
even in the presence of aneuploidy. Thus, centrosomal
proteins may be a new class of targets for cancer.
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